Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes - Top-Institutions - MDSpire

Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes

In a pooled analysis of more than 1.5 million patients, sugar-sweetened beverages were associated with higher risks of HCC and ICC, while artificially-sweetened beverages showed no independent association with hepatic cancer.

  • By

  • Andrea Surnit

  • June 10, 2026

  • 3 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Health Professionals Follow-Up Study
    Health Professionals Follow-Up Study

    Boston, MA

    Key Differentiators

    • Hepatology

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Cancer Research

  • #3

    Cancer Prevention Study-II Nutrition Cohort
    Cancer Prevention Study-II Nutrition Cohort

    Atlanta, GA

    Key Differentiators

    • Nutrition Epidemiology

  • #4

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Public Health

  • #5

    University of Oklahoma College of Medicine
    University of Oklahoma College of Medicine

    Oklahoma City, OK

    Key Differentiators

    • Medicine

Original Source(s)

Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes

  • by Andrea Surnit

  • June 10, 2026

Related Content

Semaglutide Tied to Aging Clocks in HIV

A posthoc analysis of a phase 2b trial found favorable changes in DNA methylation–based aging biomarkers among patients with human immunodeficiency virus–associated lipohypertrophy.

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

Study Reassures on Safety of Early NSAID Use

A large cohort found no adjusted link to major congenital malformations, but questions remain for miscarriage, later pregnancy, and other outcomes.